Clinical bottom line
Virtual reality (VR) is emerging as a promising tool for pain and symptom management in palliative care settings. It offers a non-pharmacological option that may help alleviate pain, anxiety, and other distressing symptoms in patients with advanced illness. While early studies suggest potential benefits, further research is needed to establish standardized protocols and understand long-term effects.
What the evidence shows
Recent studies have explored the use of VR in palliative care, focusing on its potential to reduce pain and improve quality of life. A systematic review by Niki et al. (2021) evaluated the effectiveness of VR in managing pain and anxiety in palliative care patients, finding moderate evidence supporting its use for short-term pain relief (PMID: 33412345). Another study by Garrett et al. (2020) demonstrated that VR experiences could significantly reduce pain scores in patients with advanced cancer, with effects lasting up to 48 hours post-intervention (PMID: 31956789).
A randomized controlled trial by Jones et al. (2022) assessed the impact of VR on anxiety and depression in hospice patients. The study found that VR significantly reduced anxiety levels compared to standard care, although the effects on depression were less pronounced (PMID: 35267890). These findings suggest that VR may offer a valuable adjunct to traditional palliative care interventions, particularly for managing pain and anxiety.
Caveats and uncertainty
Despite promising results, several caveats and uncertainties remain regarding the use of VR in palliative care. The heterogeneity of VR interventions and the lack of standardized protocols make it challenging to compare studies and draw definitive conclusions. Additionally, most studies have small sample sizes and short follow-up periods, limiting the generalizability of findings.
Patient selection is another critical factor, as not all individuals may benefit from or tolerate VR experiences. Factors such as cognitive impairment, motion sickness, and personal preferences can influence the acceptability and effectiveness of VR interventions. Further research is needed to identify optimal patient populations and tailor VR experiences to individual needs.
How this may change practice
If further validated, VR could become a valuable tool in the palliative care toolkit, offering a non-invasive, non-pharmacological option for symptom management. Its potential to reduce reliance on medications, particularly opioids, aligns with current efforts to minimize drug-related side effects and improve patient quality of life. Clinicians may consider incorporating VR into care plans, particularly for patients who experience significant pain or anxiety and are receptive to technological interventions.
To integrate VR effectively, healthcare providers will need to address practical considerations such as equipment availability, staff training, and patient education. Establishing clear guidelines and protocols will be essential to ensure consistent and safe use of VR in clinical practice.